Collier Pharmaceutical Service is categorized under Services (Unclassified) in Naples, FL and active since 2005.
Collier Pharmaceutical Service was established in 2005, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Services (Unclassified) business, which does work in the B2B market, and is classified as a Services (Unclassified), under code number 541990 by the NAICS.
If you are seeking more information, feel free to contact Shivsankar Misir at the company’s single location by writing to 700 2nd Avenue North, Naples, Florida FL 34102 or by phoning (239) 263-4490. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Collier Pharmaceutical Service |
| Contact Person: | Shivsankar Misir |
| Address: | 700 2nd Avenue North, Naples, Florida 34102 |
| Phone Number: | (239) 263-4490 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Services (Unclassified) |
| SIC Code: | 8999 |
| NAICS Code: | 541990 |
| Share This Business: |
Collier Pharmaceutical Service was started in 2005 to provide professional Services (Unclassified) under the SIC code 8999 and NAICS code 541990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Shivsankar Misir for inquiries that concern Collier Pharmaceutical Service by calling the company number (239) 263-4490, as your correspondence is most welcome. Additionally, the physical location of the single location of Collier Pharmaceutical Service can be found at the coordinates 26.149133,-81.798478 as well as the street address 700 2nd Avenue North in Naples, Florida 34102.
For its online presence, you may visit Collier Pharmaceutical Service’s website at and engage with its social media outlets through on Twitter and on Facebook.